yes they have - three phase 1b trials have commenced.
another phase 1 dose escalation about to commence.
which is amazing for a company with a market cap of $25m and $10m in the bank that is the lead ASX company in cell therapy in immuno-oncology
Chimeric: Media Thread, page-685
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $23.12M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.7¢ | $11.23K | 416K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 82560 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 255000 | 2 |
View Market Depth
| Last trade - 14.08pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.7¢ |
Change
0.001 ( 3.85 %) |
||||
| Open | High | Low | Volume | ||
| 2.7¢ | 2.7¢ | 2.7¢ | 17440 | ||
| Last updated 14.55pm 10/05/2024 ? | |||||
| CHM (ASX) Chart |